See more : Sonova Holding AG (SOON.SW) Income Statement Analysis – Financial Results
Complete financial analysis of CBD Life Sciences Inc. (CBDL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CBD Life Sciences Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Silver Valley Metals Corp. (SVMFF) Income Statement Analysis – Financial Results
- Corby Spirit and Wine Limited (CBYDF) Income Statement Analysis – Financial Results
- Taiwan Semiconductor Manufacturing Company Limited (TSM) Income Statement Analysis – Financial Results
- Jiangsu Flag Chemical Industry Co., Ltd. (300575.SZ) Income Statement Analysis – Financial Results
- WMD Holdings Group, Inc. (WMDH) Income Statement Analysis – Financial Results
CBD Life Sciences Inc. (CBDL)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://lbcbioscienceinc.com
About CBD Life Sciences Inc.
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 167.15K | 160.24K | 59.26K | 225.90K | 79.64K | 122.79K | 155.55K | 0.00 | 0.00 |
| Cost of Revenue | 197.75K | 440.50K | 207.51K | 438.13K | 43.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -30.60K | -280.26K | -148.25K | -212.23K | 36.63K | 122.79K | 155.55K | 0.00 | 0.00 |
| Gross Profit Ratio | -18.31% | -174.90% | -250.18% | -93.95% | 46.00% | 100.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 30.20K | 0.00 | 1.39K | 314.85 | 337.43 | 752.49K | 442.90K | 53.29K | 44.12K |
| Selling & Marketing | 11.34K | 0.00 | 4.41K | 30.00 | 111.54 | 108.00K | 17.48K | 6.46K | 8.02K |
| SG&A | 46.05K | 571.77K | 4.96M | 171.86K | 906.25K | 860.49K | 460.38K | 59.75K | 52.14K |
| Other Expenses | 0.00 | -7.78K | -17.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 47.97K | 579.55K | 4.98M | 171.86K | 906.25K | 883.80K | 499.04K | 155.72K | 52.74K |
| Cost & Expenses | 245.72K | 1.02M | 5.19M | 609.99K | 949.26K | 883.80K | 499.04K | 155.72K | 52.74K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 69.91K | 0.00 | 15.27K | 23.50K | 0.00 | 0.00 |
| Depreciation & Amortization | 55.56K | 53.56K | 236.56K | 206.30K | 171.86K | 23.31K | 38.66K | 95.97K | 0.00 |
| EBITDA | -23.02K | -806.25K | -5.13M | -1.31M | -869.62K | -741.56K | -304.97K | -60.36K | -52.74K |
| EBITDA Ratio | -13.77% | -503.14% | -8,654.23% | -170.03% | -1,092.01% | -600.79% | -195.96% | 0.00% | 0.00% |
| Operating Income | -78.57K | -859.80K | -5.13M | -384.09K | -869.62K | -780.14K | -367.14K | -156.33K | -52.74K |
| Operating Income Ratio | -47.01% | -536.57% | -8,654.23% | -170.03% | -1,092.01% | -635.35% | -236.02% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | -4.00 | -2.00 | -1.31M | 8.61K | -15.27K | -23.50K | 0.00 | 0.00 |
| Income Before Tax | -78.57K | -859.80K | -5.13M | -1.69M | -861.01K | -780.14K | -367.14K | -156.33K | -52.74K |
| Income Before Tax Ratio | -47.01% | -536.57% | -8,654.24% | -750.07% | -1,081.20% | -635.35% | -236.02% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 4.00 | -6.14K | -384.09 | -75.24 | 15.27K | 23.50K | 610.00 | 0.00 |
| Net Income | -78.57K | -859.80K | -5.13M | -1.69M | -861.01K | -780.14K | -367.14K | -156.33K | -52.74K |
| Net Income Ratio | -47.01% | -536.57% | -8,654.24% | -750.07% | -1,081.20% | -635.35% | -236.02% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -428.18 | -2.29K | -2.41K | -893.95 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -428.18 | -2.29K | -2.41K | -893.95 |
| Weighted Avg Shares Out | 40.71B | 40.71B | 12.30B | 934.78M | 108.36M | 1.82K | 160.00 | 65.00 | 59.00 |
| Weighted Avg Shares Out (Dil) | 40.71B | 40.71B | 12.30B | 934.78M | 108.36M | 1.82K | 160.00 | 65.00 | 59.00 |
CBD Life Sciences, Inc. (CBDL) Welcomes Major Political Endorsement for Cannabis Legalization
SCOTTSDALE, AZ / ACCESSWIRE / August 12, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly owned subsidiary, The CBD Vault Inc., a rapidly expanding CBD company headquartered in Scottsdale, Arizona, proudly supports the recent endorsement of cannabis...
CBD Life Sciences, Inc. (CBDL) Signs MOU With Large Mushroom Supplement Company
SCOTTSDALE, AZ / ACCESSWIRE / August 1, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it's signed a MOU (Memorandum of understanding)...
CBDL's Expansion Into New Area Sparks More Revenue Growth + Other Updates
SCOTTSDALE, AZ / ACCESSWIRE / July 31, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it's going expand into new areas including...
Recent Developments in New Sales Channels Fuel CBDL's 18-Month Sales Projections; Company's CBD VaultTM Products' Projected 2025 Sales Revenues to Reach $1.8 Million
SCOTTSDALE, AZ / ACCESSWIRE / July 23, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, today announced increasing its revenue projection for 2025 to $1.8...
CBD Life Sciences, Inc. (CBDL) Announces Corporate Executive Jennifer Simmons
SCOTTSDALE, AZ / ACCESSWIRE / July 19, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading company in the CBD industry, is proud to announce the addition of Jennifer Simmons as the new General Manager. Jennifer is a highly...
CBD Life Sciences, Inc. (CBDL) Completes Partnership with Arizona's Largest CBD Wholesaler
SCOTTSDALE, AZ / ACCESSWIRE / July 16, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its dynamic subsidiary The CBD Vault Inc, is thrilled to announce a transformative partnership with Sunset Wholesale West, the premier wholesaler in Arizona. The...
CBD Life Sciences, Inc. (CBDL) Announces Major Distribution: Premium CBD Pain Relief Cream Now Available at Red Hots Spa in Long Island, New York
SCOTTSDALE, AZ / ACCESSWIRE / July 15, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. is thrilled to announce that its high-strength CBD Pain Relief Cream is now available at the...
CBD Life Sciences, Inc. (CBDL) Launches New Line of Kava & Kratom Shots
SCOTTSDALE, AZ / ACCESSWIRE / July 10, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. a leader in the CBD industry, is excited to announce the launch of its new line...
CBD Life Sciences, Inc. (CBDL) Looking to Expand Its Brand into Retail Stores Nationwide
SCOTTSDALE, AZ / ACCESSWIRE / June 27, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. a leading innovator in the CBD industry, is thrilled to announce its strategic initiative to expand...
CBD Life Sciences Inc. Provides Shareholder Letter Update
SCOTTSDALE, AZ / ACCESSWIRE / June 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. (Formerly LBC Bioscience Inc.) is delighted to announce the transformation of LBC Bioscience Inc. into The...
Source: https://incomestatements.info
Category: Stock Reports